{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:44:57Z","timestamp":1763037897039,"version":"build-2065373602"},"reference-count":26,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Current medication therapy for leishmaniasis and trypanosomiasis remains a major challenge due to its limited efficacy, significant adverse effects, and inaccessibility. Consequently, locating affordable and effective medications is a pressing concern. Because of their easy-to-understand structure and high functionalization potential, chalcones are promising candidates for use as bioactive agents. Thirteen synthetic ligustrazine-containing chalcones were evaluated for their ability to inhibit the growth of leishmaniasis and trypanosomiasis in etiologic agents. The tetramethylpyrazine (TMP) analogue ligustrazine was chosen as the central moiety for the synthesis of these chalcone compounds. The most effective compound (EC50 = 2.59 \u00b5M) was the chalcone derivative 2c, which featured a pyrazin-2-yl amino on the ketone ring and a methyl substitution. Multiple actions were observed for certain derivatives, including 1c, 2a\u2013c, 4b, and 5b, against all strains tested. Eflornithine served as a positive control, and three ligustrazine-based chalcone derivatives, including 1c, 2c, and 4b, had a higher relative potency. Compounds 1c and 2c are particularly efficacious; even more potent than the positive control, they are therefore promising candidates for the treatment of trypanosomiasis and leishmaniasis.<\/jats:p>","DOI":"10.3390\/molecules28124652","type":"journal-article","created":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T02:03:18Z","timestamp":1686276198000},"page":"4652","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effects of Synthetic Ligustrazine-Based Chalcone Derivatives on Trypanosoma brucei brucei and Leishmania spp. Promastigotes"],"prefix":"10.3390","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4170-0030","authenticated-orcid":false,"given":"Abdulsalam A. M.","family":"Alkhaldi","sequence":"first","affiliation":[{"name":"Biology Department, College of Science, Jouf University, Sakaka 72341, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41586-018-0327-4","article-title":"Challenges and recent progress in drug discovery for tropical diseases","volume":"559","author":"Duce","year":"2018","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Kourbeli, V., Chontzopoulou, E., Moschovou, K., Pavlos, D., Mavromoustakos, T., and Papanastasiou, I.P. (2021). An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases. Molecules, 26.","DOI":"10.3390\/molecules26154629"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"105906","DOI":"10.1016\/j.ijantimicag.2020.105906","article-title":"Searching for drugs for Chagas disease, leishmaniasis and schistosomiasis: A review","volume":"55","author":"Santos","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1756-3305-1-3","article-title":"The history of African trypanosomiasis","volume":"1","author":"Steverding","year":"2008","journal-title":"Parasites Vectors"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/S0140-6736(03)14694-6","article-title":"The trypanosomiases","volume":"362","author":"Barrett","year":"2003","journal-title":"Lancet"},{"key":"ref_6","unstructured":"(2023, March 02). Trypanosomiasis, Human African (Sleeping Sickness). Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/trypanosomiasis-human-african-(sleeping-sickness)."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Dize, D., Tata, R.B., Keumoe, R., Kouipou Toghueo, R.M., Tchatat, M.B., Njanpa, C.N., Tchuenguia, V.C., Yamthe, L.T., Fokou, P.V.T., and Laleu, B. (2022). Preliminary Structure\u2014Activity Relationship Study of the MMV Pathogen Box Compound MMV675968 (2,4-Diaminoquinazoline) Unveils Novel Inhibitors of Trypanosoma brucei brucei. Molecules, 27.","DOI":"10.1101\/2022.05.20.492762"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1017\/S0031182016001268","article-title":"The animal trypanosomiases and their chemotherapy: A review","volume":"143","author":"Giordani","year":"2016","journal-title":"Parasitology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ijpddr.2017.10.002","article-title":"Genomic analysis of Isometamidium Chloride resistance in Trypanosoma congolense","volume":"7","author":"Tihon","year":"2017","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/pim.12387","article-title":"Prospects for vaccination against pathogenic African trypanosomes","volume":"38","author":"Black","year":"2016","journal-title":"Parasite Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1002\/jctb.6633","article-title":"Overcoming multi-resistant leishmania treatment by nanoencapsulation of potent antimicrobials","volume":"96","author":"Oliveira","year":"2021","journal-title":"J. Chem. Technol. Biotechnol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Rasheed, Z., Ahmed, A.A., Salem, T., Al-Dhubaibi, M.S., Al Robaee, A.A., and Alzolibani, A.A. (2019). Prevalence of Leishmania species among patients with cutaneous leishmaniasis in Qassim province of Saudi Arabia. BMC Public Health, 19.","DOI":"10.1186\/s12889-019-6710-8"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.33263\/BRIAC132.135","article-title":"Activity of benzimidazole derivatives and their N-heterocyclic carbene silver complexes against Leishmania major promastigotes and amastigotes","volume":"13","author":"Khan","year":"2022","journal-title":"Biointerface Res. Appl. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1186\/s13071-021-04961-6","article-title":"Evaluation of molecular assays to detect Leishmania donovani in Phlebotomus argentipes fed on post-kala-azar dermal leishmaniasis patients","volume":"14","author":"Khan","year":"2021","journal-title":"Parasites Vectors"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fpubh.2020.00011","article-title":"The Geographical Distribution of Cutaneous Leishmaniasis Causative Agents in Iran and Its Neighboring Countries, A Review","volume":"8","author":"Ghatee","year":"2020","journal-title":"Front. Public Health"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1007\/s00436-021-07166-z","article-title":"Molecular characterization of Leishmania species from stray dogs and human patients in Saudi Arabia","volume":"120","author":"Alanazi","year":"2021","journal-title":"Parasitol. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"105707","DOI":"10.1016\/j.actatropica.2020.105707","article-title":"Visceral leishmaniasis in Saudi Arabia: From hundreds of cases to zero","volume":"212","author":"Abuzaid","year":"2020","journal-title":"Acta Trop."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"112016","DOI":"10.1016\/j.jinorgbio.2022.112016","article-title":"New multifunctional Ru(II) organometallic compounds show activity against Trypanosoma brucei and Leishmania infantum","volume":"237","author":"Rivas","year":"2022","journal-title":"J. Inorg. Biochem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e18997","DOI":"10.1590\/s2175-97902020000418997","article-title":"Synthetic ligustrazine based cyclohexanone and oxime analogs as Anti-Trypanosoma and Anti-Leishmanial agentes","volume":"57","author":"Alkhaldi","year":"2021","journal-title":"Braz. J. Pharm. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/cbdd.13355","article-title":"Synthesis and biological evaluation of new tetramethylpyrazine-based chalcone derivatives as potential anti-Alzheimer agents","volume":"92","author":"Wang","year":"2018","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ejmech.2019.02.028","article-title":"Novel prenyloxy chalcones as potential leishmanicidal and trypanocidal agents: Design, synthesis and evaluation","volume":"167","author":"Tamariz","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez-Rivera, J.L., Espinoza-Hicks, J.C., Chac\u00f3n-Vargas, K.F., Carrillo-Campos, J., S\u00e1nchez-Torres, L.E., and Camacho-D\u00e1vila, A.A. (2022). Synthesis, characterization and evaluation of prenylated chalcones ethers as promising antileishmanial compounds. Mol. Divers., ahead of print.","DOI":"10.1007\/s11030-022-10542-1"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2307\/3282883","article-title":"Continuous cultivation of Trypanosoma brucei blood stream forms in a medium containing a low concentration of serum protein without feeder cell layers","volume":"75","author":"Hirumi","year":"1989","journal-title":"J. Parasitol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.resmic.2004.01.001","article-title":"In vitro assays for evaluation of drug activity against Leishmania spp","volume":"155","author":"Fumarola","year":"2004","journal-title":"Res. Microbiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0001-706X(97)00079-X","article-title":"The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro","volume":"68","author":"Raz","year":"1997","journal-title":"Acta Trop."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1124\/mol.63.4.814","article-title":"A Leishmania major Nucleobase Transporter Responsible for Allopurinol Uptake Is a Functional Homolog of the Trypanosoma brucei H2 Transporter","volume":"63","author":"Wallace","year":"2003","journal-title":"Mol. Pharmacol."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/12\/4652\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:51:05Z","timestamp":1760125865000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/12\/4652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,8]]},"references-count":26,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["molecules28124652"],"URL":"https:\/\/doi.org\/10.3390\/molecules28124652","relation":{},"ISSN":["1420-3049"],"issn-type":[{"type":"electronic","value":"1420-3049"}],"subject":[],"published":{"date-parts":[[2023,6,8]]}}}